

![]() |
|||||||||||||
|
| All | Since 2020 | |
| Citation | 6651 | 4087 |
| h-index | 26 | 21 |
| i10-index | 174 | 83 |
Search
News & Updation
FORMULATION AND EVALUATION OF GLIPIZIDE MICROEMULSION
Aravind Singh*, Prof. (Dr.) Pankaj Kumar Sharma, Prof. (Dr.) Jaya Sharma, Prof. (Dr.) Samir Gaur, Dr. Maneesh Napit
ABSTRACT Glipizide is a second-generation sulfonylurea used in the treatment of Type 2 diabetes mellitus. Because of its poor aqueous solubility (BCS Class II), its oral bioavailability is limited by a slow dissolution rate. Microemulsion-based drug delivery systems are thermodynamically stable, isotropic dispersions of oil, water, surfactant, and co-surfactant that enhance the solubility, dissolution, and bioavailability of poorly water-soluble drugs. In this study, glipizide microemulsion is formulated using the water titration method after selection of suitable oil, surfactant, and co-surfactant based on solubility studies and pseudo-ternary phase diagrams. The optimized formulation is evaluated for droplet size, polydispersity index, zeta potential, pH, viscosity, conductivity, percentage transmittance, drug content, in-vitro drug release, and stability. Studies have shown that optimized glipizide microemulsions ] can achieve >90% drug release with nanosized droplets and good physical stability, indicating their potential to improve oral drug delivery. Keywords: Glipizide; Microemulsion; Oral Drug Delivery; Solubility Enhancement; Bioavailability; Pseudo-ternary Phase Diagram; In-vitro Drug Release; Stability Study. [Download Article] [Download Certifiate] |
